Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Imfinzi approved in the US for endometrial cancer

17 June 2024   Imfinzi plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy   AstraZeneca’s Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (dMMR).1   The approval by the Food and

CapMan Real Estate announces strategic promotions and new role to bolster Nordic asset management

CapMan Real Estate press release17.6.2024 at 09:00 AM EEST CapMan Real Estate announces strategic promotions and new role to bolster Nordic asset management CapMan Real Estate makes key organisational enhancements including the introduction of a new leadership role to streamline Nordic asset management operations and support continued expansion. Over recent five years, CapMan Real Estate has experienced substantial growth, with gross asset value under management surging by over €1 billion, reaching approximately €4.4 billion. The pan-Nordic team has also seen significant growth,

Invitation to presentation of Alligo’s Interim Report for the second quarter 2024

Alligo will publish its Interim Report for the second quarter on Wednesday July 17, 2024 at 8:00 a.m. CEST. In conjunction with this, Alligo is pleased to issue this invitation to a webcast conference call in which CEO & President Clein Johansson Ullenvik and CFO Irene Wisenborn Bellander will present the report and answer any subsequent questions.The conference call and presentation are available on the web or by telephone in accordance with the details below. Questions can be asked via the webcast  (written) or by logging in to the conference

The last day for trading in Moberg Pharma's warrants of series 2023:1 (TO 2) is today, June 17[th], 2024

Today, June 17[th], 2024, is the last day for trading in Moberg Pharma AB's (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2023:1 (“TO 2”). The exercise period runs until June 19[th], 2024.In 2023, Moberg Pharma carried out a rights issue of units which was oversubscribed to approximately 130%. Each unit consisted of one (1) ordinary share and one (1) warrant in Moberg Pharma. One (1) warrant of TO 2 entitles the holder to subscribe for one (1) new ordinary share in Moberg Pharma. The subscription price is SEK 18.00 per share. TO 2 in briefEach TO 2 entitles the holder

Volvo Defense at Eurosatory 2024: a complete solution designed for the toughest conditions

At this year’s Eurosatory – the world’s largest international defence and security exhibition – Volvo Defense will be showcasing how equipment from Volvo Trucks, Volvo Penta, and Volvo Construction Equipment can offer customers the highest level of flexibility and security of supply.The Volvo Defense offer is built on the strength of the Volvo Group, having a unique product range for the military defence and civilian protection segment. “I’m excited to meet and interact with customers and industry stakeholders at Eurosatory – Volvo Defense has a stronger offer than ever before”, says

Transaction in Own Shares

    17 June 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |14/06/2024|+--------------------------------------------------------------

Olvi plc: Transfer of Treasury Shares Under a Matching Share Plan

Olvi plc           Stock Exchange Release 17 June 2024 at 9.00 am Olvi plc: Transfer of Treasury Shares Under a Matching Share Plan The Board of Directors of Olvi plc has resolved on directed issuance of shares without consideration to transfer a total of 400 Olvi plc Series A shares held as treasury shares to the company's key employees under a Matching Share Plan 2022–2023. In the plan, the target group was given an opportunity to receive matching shares for their personal investment in Olvi plc series A shares. The rewards depend on the validity of the employment relationship at

Africa Oil Announces Results of Share Buyback Program

VANCOUVER, BC, June 17, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 1,244,300 Africa Oil common shares during the period of June 10, 2024 to June 14, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/1052 (

Norconsult ASA: Employee Share Programs 2024

Sandvika, 17 June 2024(OSE: NORCO): In connection with Norconsult’s Employee Share Programs 2024, 3 839 employees purchased a total of 2 885 363 shares. The share programs were substantially oversubscribed, hence the allocation of shares was reduced in order to meet the previously communicated cost frame for the program. The Share Programs include a program for discounted shares and matching shares, as well as programs for executive management and other key employees. For discounted shares, the purchase price is equal to the volume-weighted average share price for the Company's shares on

SRV and Metsä Group reach agreement on the development phase of a fibre products factory

SRV GROUP PLC     INVESTOR NEWS    17 JUNE 2024  09:00 EEST SRV and Metsä Group reach agreement on the development phase of a fibre products factory SRV and Metsä Group have signed an agreement to start the development phase of a new fibre products factory of approximately 20,000 square metres to be designed on the Rauma factory area. The new packaging materials production facility using wood fibres would use a completely new manufacturing method. The goal of preliminary planning during the development phase is to find out the project's investment suitability by the turn of the year.

Sobi to present new haemophilia data at ISTH 2024

Sobi® will present new scientific data related to haemophilia at ISTH 2024, the 32nd Congress of the International Society on Thrombosis and Haemostasis. This event, taking place from 22nd to 26th June, will be held both online and in Bangkok. Seven abstracts have been accepted for presentation (three posters and four oral). New long-term safety and efficacy data on efanesoctocog alfa and long-term efficacy data on Elocta will be presented further demonstrating Sobi's commitment to advancing standards of care in haemophilia A treatment.   “We are pleased to present new data at this

Kemira Oyj: Announcement of manager’s transaction; Esa-Matti Puputti, EVP, Operational Excellence & Sustainability has sold 15,000 Kemira shares

Kemira Oyj, Managers' transactions, June 17, 2024 at 9.00 am (EEST)Kemira Oyj: Announcement of manager’s transaction; Esa-Matti Puputti, EVP, Operational Excellence & Sustainability has sold 15,000 Kemira sharesKemira has received a notification from Esa-Matti Puputti, EVP, Operational Excellence & Sustainability, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below. Person subject to the notification requirementName: Esa-Matti PuputtiPosition: Other senior managerIssuer:

Samhällsbyggnadsbolaget i Norden AB initiates a buy-back programme for ordinary shares of Class D

The board of directors of Samhällsbyggnadsbolaget i Norden AB (“SBB”) has, based on the authorisation from the annual general meeting held on 28 April 2023, resolved to initiate a buy-back programme of ordinary shares of Class D. SBB works actively to strengthen its ability to raise competitive financing and to create the most optimal capital structure possible. What constitutes an optimal capital structure changes over time and SBB therefore needs to continuously adjust the use of various financing products. In parallel with the strategy of creating independent business areas, the

Gaming Innovation Group is contemplating a bond tap issue

Gaming Innovation Group Inc. ("GiG") has mandated ABG Sundal Collier and Pareto Securities as managers to arrange a series of fixed income investor meetings commencing on 17 June 2024. GiG is contemplating to issue subsequent bonds under GiG’s existing senior secured bond framework with ISINs NO0013024018 (the “EUR-tranche”) and NO0013095687 the (“SEK-tranche) in an expected amount of EUR 15 million equivalent. Subject to, inter alia, market conditions a capital markets transaction may follow.  For further information, please contact:Tore Formo, Group CFO, tore@gig.com, +47 91668678

Essity decides to buy back shares for SEK 3bn

Essity's Board of Directors has resolved to utilize the authorization granted by the Annual General Meeting on March 21, 2024, and initiate a program to buy back Class B shares in Essity for SEK 3bn.Essity’s Board of Directors has today resolved to utilize the authorization granted by the Annual General Meeting on March 21, 2024, and initiate a program to buy back Class B shares in Essity for SEK 3bn, but not exceeding 10% of the total number of shares outstanding. The buyback program begins on June 17, 2024, and extends until the 2025 Annual General Meeting. The repurchased shares are

Essity presents new financial targets

Hygiene and health company Essity is today presenting new financial targets based on the company’s portfolio following the divestment of the subsidiary Vinda. The new targets are an increase in ambition with an emphasis on profitable growth and are based on the company’s robust platform with leading positions in growing and attractive markets. The targets will be presented at a live webcast and teleconference today at 09:00 CET.Essity’s new financial targets:  Annual organic sales growth >3% Essity’s new target is annual organic sales growth of more than 3%. The previous target was an

Gaming Innovation Group signs heads-of-terms to acquire Titan - strengthening SEO and content services

Gaming Innovation Group Inc. (“GiG”), a leader in digital marketing and media within the online gaming sector, has signed a head-of-terms agreement to acquire Titan Inc. Limited (“Titan”), a premier supplier of SEO and content services. This strategic acquisition will significantly enhance Gaming Innovation Group's operational efficiency and market position. The anticipated cost savings and operational efficiencies underscore the strategic rationale for this acquisition. For operations moved to Titan, GiG Media’s SEO and content costs are expected to be reduced by up to 50%. Furthermore,

Sweco selected as strategic advisor by The Danish Ministry of Defence Estate Agency in EUR 21 million agreement

Sweco has been awarded a four-year framework agreement worth approximately EUR 21 million by the Danish Ministry of Defence Estate Agency (MDEA). In this assignment, Sweco will be solely responsible for providing strategic consultancy in the construction, maintenance, development and sustainability of military operative properties across Denmark, the Faroe Islands and Greenland.The MDEA “Forsvarsministeriets Ejendomsstyrelse” manages and expands military facilities such as barracks, naval bases, air force stations, shooting ranges, training grounds and other property on behalf of the Danish

Read original

BlueNord: Successful Spudding of Harald East Middle Jurassic Well

Oslo, 17 June 2024: BlueNord ASA ("BlueNord" or the "Company") is pleased to announce that drilling operations on the Harald East Middle Jurassic well ("HEMJ") has commenced with the well successfully spudded by the jackup rig Shelf Drilling Winner. The HEMJ was spudded in the Harald East area, located close to the Norwegian border and the gas will be exported through the Tyra East facilities. In a success case, the well could deliver production by end of 2024. The expected gain from the well is estimated to up to 8 mmboe net to BlueNord of which approximately 80% is expected to be gas.

Preclinical data for Cereno Scientific’s drug candidate CS585 showing high selectivity for the IP receptor presented at the EHA 2024 Hybrid Congress

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that an abstract on the preclinical drug candidate, novel IP receptor agonist CS585, was presented at the EHA 2024 Hybrid Congress, in Madrid, June 15th, 2024.The abstract titled “Superior Selectivity of CS585 to The Prostacyclin Receptor Translates to A New Viable Target for Prevention of Thrombosis”, was authored by L. Stanger, P Yalavarthi, A. Rickenberg, K. Goerger, D. Gilmore and M. Holinstat, at University of Michigan, Ann

Immedica’s partner Actinium announces Iomab-B phase 3 SIERRA trial results in patients with TP53 mutation at the EHA 2024 Annual Congress

Stockholm, June 15, 2024 - Immedica’s partner Actinium Pharmaceuticals, Inc. announced results from the Phase 3 SIERRA trial of Iomab-B in patients with a TP53 mutation in an oral presentation at the 2024 European Hematology Association (EHA) Hybrid Congress being held June 13 – 16, 2024, in Madrid, Spain. The Phase 3 SIERRA trial enrolled 153 patients with active relapsed or refractory acute myeloid leukemia (r/r AML) and compared outcomes of patients receiving Iomab-B and allogeneic haematopoietic stem cell transplantation (alloHSCT) to those of patients receiving physician's choice of

Betolar Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (Juha Markus Leppänen)

Betolar Plc Company announcement 15 June 2024 at 6:00 AM EEST Betolar Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (Juha Markus Leppänen) Betolar Plc has received a notification on June 14, 2024, according to Chapter 9, Section 5 of the Securities Markets Act, stating that Juha Markus Leppänen’s ownership of shares exceeds 15% of all shares and votes in Betolar Plc. Leppänen’s ownership exceeded the notification threshold before April 19, 2024. The notification of exceeding the ownership threshold is

There are no items matching the current filter
There are no more items matching the current filter
Back to top